Cargando…

Antiviral Efficacy of Pralatrexate against SARS-CoV-2

Novel coronavirus (SARS-CoV-2) has caused more than 100 million confirmed cases of human infectious disease (COVID-19) since December 2019 to paralyze our global community. However, only limited access has been allowed to COVID-19 vaccines and antiviral treatment options. Here, we report the efficac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bae, Joon-Yong, Lee, Gee Eun, Park, Heedo, Cho, Juyoung, Kim, Jeonghun, Lee, Jungmin, Kim, Kisoon, Kim, Jin Il, Park, Man-Seong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Applied Pharmacology 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094065/ https://www.ncbi.nlm.nih.gov/pubmed/33731494 http://dx.doi.org/10.4062/biomolther.2021.032

Ejemplares similares

Molecular evolution and targeted recombination of SARS-CoV-2 in South Korea
por: Demirev, Atanas V., et al.
Publicado: (2023)

A high-resolution temporal atlas of the SARS-CoV-2 translatome and transcriptome
por: Kim, Doyeon, et al.
Publicado: (2021)

Kinetics of neutralizing antibodies against SARS-CoV-2 infection according to sex, age, and disease severity
por: Kim, Yoonjung, et al.
Publicado: (2022)

Insights into the immune responses of SARS-CoV-2 in relation to COVID-19 vaccines
por: Park, Heedo, et al.
Publicado: (2022)

The Immune Correlates of Orthohantavirus Vaccine
por: Bae, Joon-Yong, et al.
Publicado: (2021)

Multifactorial Traits of SARS-CoV-2 Cell Entry Related to Diverse Host Proteases and Proteins
por: You, Jaehwan, et al.
Publicado: (2021)

Diagnostic usefulness of subgenomic RNA detection of viable SARS-CoV-2 in patients with COVID-19
por: Kim, Ji Yeun, et al.
Publicado: (2022)

Comparison of culture-competent virus shedding duration of SARS-CoV-2 Omicron variant in regard to vaccination status: A prospective cohort study
por: Kang, Sung-Woon, et al.
Publicado: (2023)

Daily, self-test rapid antigen test to assess SARS-CoV-2 viability in de-isolation of patients with COVID-19
por: Bae, Seongman, et al.
Publicado: (2022)

Pralatrexate in Combination with Bortezomib for Relapsed or Refractory Peripheral T Cell Lymphoma in 5 Elderly Patients
por: Lee, Seung-Shin, et al.
Publicado: (2016)

Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals
por: Jung, Jiwon, et al.
Publicado: (2022)

Nosocomial Outbreak by Delta Variant From a Fully Vaccinated Patient
por: Jung, Jiwon, et al.
Publicado: (2022)

Comparison of the clinical and virological characteristics of SARS-CoV-2 Omicron BA.1/BA.2 and omicron BA.5 variants: A prospective cohort study
por: Kang, Sung-Woon, et al.
Publicado: (2023)

Towards the Application of Human Defensins as Antivirals
por: Park, Mee Sook, et al.
Publicado: (2018)

Comparison of outward transmission potential between vaccinated and partially vaccinated or unvaccinated individuals with the SARS-CoV-2 delta variant infection
por: Kang, Sung Woon, et al.
Publicado: (2022)

Pralatrexate in patients with recurrent or refractory peripheral T-cell lymphomas: a multicenter retrospective analysis
por: Hong, Jung Yong, et al.
Publicado: (2019)

Evaluation of In-Hospital Cluster of COVID-19 Associated With a Patient With Prolonged Viral Shedding Using Whole-Genome Sequencing
por: Jung, Jiwon, et al.
Publicado: (2022)

Corrigendum to “Comparison of outward transmission potential between vaccinated and partially vaccinated or unvaccinated individuals with the SARS-CoV-2 delta variant infection” [J Infect 85 (2022) e69–e71]
por: Kang, Sung Woon, et al.
Publicado: (2023)

Performance Evaluation of the BZ COVID-19 Neutralizing Antibody Test for the Culture-Free and Rapid Detection of SARS-CoV-2 Neutralizing Antibodies
por: Jung, Bo Kyeung, et al.
Publicado: (2021)

Mutational analysis of severe acute respiratory syndrome coronavirus 2 in immunocompromised patients with persistent viral detection using whole genome sequencing
por: Chang, Euijin, et al.
Publicado: (2023)

Analysis of spike protein variants evolved in a novel in vivo long-term replication model for SARS-CoV-2
por: Kim, Dongbum, et al.
Publicado: (2023)

Single PA mutation as a high yield determinant of avian influenza vaccines
por: Lee, Ilseob, et al.
Publicado: (2017)

A Single Amino Acid in the Polymerase Acidic Protein Determines the Pathogenicity of Influenza B Viruses
por: Bae, Joon-Yong, et al.
Publicado: (2018)

Pralatrexate for refractory mycosis fungoides in two Japanese patients
por: Teraishi, Mika, et al.
Publicado: (2021)

Neutralizing Antibody Responses to SARS-CoV-2 in Korean Patients Who Have Recovered from COVID-19
por: Kim, Yoon-Jung, et al.
Publicado: (2021)

Cost-utility analysis of pralatrexate for relapsed or refractory peripheral T-cell lymphoma based on a case-matched historical control study along with single arm clinical trial
por: Park, Seonyoung, et al.
Publicado: (2020)

Frequent Occurrence of SARS-CoV-2 Transmission among Non-close Contacts Exposed to COVID-19 Patients
por: Jung, Jiwon, et al.
Publicado: (2021)

Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment
por: Yoon, Jin Gu, et al.
Publicado: (2022)

Safety and Efficacy of Pralatrexate in the Management of Relapsed or Refractory Peripheral T-cell Lymphoma
por: Rodd, Annabelle L., et al.
Publicado: (2012)

Author Correction: Development of the H3N2 influenza microneedle vaccine for cross-protection against antigenic variants
por: Shin, Yura, et al.
Publicado: (2022)

Development of the H3N2 influenza microneedle vaccine for cross-protection against antigenic variants
por: Shin, Yura, et al.
Publicado: (2022)

Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets
por: Park, Su-Jin, et al.
Publicado: (2020)

464. Whole Genome Sequencing and Mutation Analysis of SARS-CoV-2 in the Immunocompromised Patients with Persistent SARS-CoV-2 Shedding
por: Chang, Eui Jin, et al.
Publicado: (2023)

Preclinical evaluation of the anti-tumor activity of pralatrexate in high-risk neuroblastoma cells
por: Clark, Rachael A., et al.
Publicado: (2020)

Single agent and combination studies of pralatrexate and molecular correlates of sensitivity
por: Serova, M, et al.
Publicado: (2011)

Glycosylation generates an efficacious and immunogenic vaccine against H7N9 influenza virus
por: Kim, Jin Il, et al.
Publicado: (2020)

Original Antigenic Sin Response to RNA Viruses and Antiviral Immunity
por: Park, Mee Sook, et al.
Publicado: (2016)

MG1141A as a Highly Potent Monoclonal Neutralizing Antibody Against SARS-CoV-2 Variants
por: Lee, Sua, et al.
Publicado: (2021)

Amelioration of SARS-CoV-2 infection by ANO6 phospholipid scramblase inhibition
por: Sim, Ju-Ri, et al.
Publicado: (2022)

MERS-CoV and SARS-CoV-2 replication can be inhibited by targeting the interaction between the viral spike protein and the nucleocapsid protein
por: Park, Byoung Kwon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_87fq831t62m2gi486vek3v2tkj